Guangzhou Kingmed Diagnostics Group Co., Ltd. (SHA:603882)
China
· Delayed Price · Currency is CNY 27.74
+0.10 (0.36%)
Apr 28, 2025, 2:45 PM CST
SHA:603882 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Operating Revenue | 6,815 | 7,190 | 7,726 | 14,529 | 11,304 | 7,870 | Upgrade
|
| Other Revenue | - | - | 813.43 | 946.76 | 639.52 | 373.96 | Upgrade
|
| Revenue | 6,815 | 7,190 | 8,540 | 15,476 | 11,943 | 8,244 | Upgrade
|
| Revenue Growth (YoY) | -17.53% | -15.81% | -44.82% | 29.58% | 44.88% | 56.45% | Upgrade
|
| Cost of Revenue | 4,535 | 4,807 | 5,425 | 8,802 | 6,295 | 4,395 | Upgrade
|
| Gross Profit | 2,280 | 2,383 | 3,115 | 6,674 | 5,648 | 3,849 | Upgrade
|
| Selling, General & Admin | 1,490 | 1,529 | 1,730 | 2,506 | 2,323 | 1,613 | Upgrade
|
| Research & Development | 385.45 | 400.47 | 467.14 | 632.62 | 517.93 | 397.17 | Upgrade
|
| Other Operating Expenses | -24.66 | -23.67 | 14.91 | 14.75 | 11.71 | 6.93 | Upgrade
|
| Operating Expenses | 1,851 | 1,905 | 2,700 | 3,409 | 2,924 | 2,064 | Upgrade
|
| Operating Income | 429.06 | 477.6 | 414.93 | 3,266 | 2,724 | 1,785 | Upgrade
|
| Interest Expense | - | - | -20.39 | -23.65 | -27.55 | -29.26 | Upgrade
|
| Interest & Investment Income | 0.64 | - | 288.36 | 30.4 | 21.53 | 13.76 | Upgrade
|
| Earnings From Equity Investments | 2.38 | - | - | - | - | - | Upgrade
|
| Currency Exchange Gain (Loss) | - | - | -0.6 | 9.14 | -1.46 | -0.2 | Upgrade
|
| Other Non Operating Income (Expenses) | -746.07 | -782.11 | -2.95 | -3.91 | -2.54 | -2.03 | Upgrade
|
| EBT Excluding Unusual Items | -313.99 | -304.51 | 679.35 | 3,278 | 2,714 | 1,767 | Upgrade
|
| Gain (Loss) on Sale of Investments | -67.88 | -67.88 | - | -10.8 | -7.29 | -18.66 | Upgrade
|
| Gain (Loss) on Sale of Assets | 5.4 | 6.36 | -7.57 | 2.97 | -10.11 | 1.43 | Upgrade
|
| Asset Writedown | -72.68 | -72.62 | - | - | - | - | Upgrade
|
| Other Unusual Items | - | - | 68.51 | 50.64 | 50.87 | 60.42 | Upgrade
|
| Pretax Income | -449.15 | -438.65 | 740.29 | 3,321 | 2,748 | 1,810 | Upgrade
|
| Income Tax Expense | -26.14 | -23.94 | 103.38 | 475.72 | 384.05 | 237.04 | Upgrade
|
| Earnings From Continuing Operations | -423.01 | -414.7 | 636.91 | 2,845 | 2,364 | 1,573 | Upgrade
|
| Minority Interest in Earnings | 32.62 | 33.46 | 6.47 | -90.22 | -143.87 | -63.73 | Upgrade
|
| Net Income | -390.39 | -381.24 | 643.38 | 2,755 | 2,220 | 1,510 | Upgrade
|
| Net Income to Common | -390.39 | -381.24 | 643.38 | 2,755 | 2,220 | 1,510 | Upgrade
|
| Net Income Growth | - | - | -76.64% | 24.11% | 47.02% | 275.24% | Upgrade
|
| Shares Outstanding (Basic) | 464 | 465 | 466 | 466 | 462 | 459 | Upgrade
|
| Shares Outstanding (Diluted) | 464 | 465 | 466 | 467 | 466 | 462 | Upgrade
|
| Shares Change (YoY) | -0.34% | -0.28% | -0.15% | 0.13% | 1.00% | 0.98% | Upgrade
|
| EPS (Basic) | -0.84 | -0.82 | 1.38 | 5.91 | 4.80 | 3.29 | Upgrade
|
| EPS (Diluted) | -0.84 | -0.82 | 1.38 | 5.90 | 4.76 | 3.27 | Upgrade
|
| EPS Growth | - | - | -76.61% | 23.95% | 45.57% | 271.59% | Upgrade
|
| Free Cash Flow | 643.26 | 459.99 | 516.07 | 1,107 | 1,136 | 972.45 | Upgrade
|
| Free Cash Flow Per Share | 1.39 | 0.99 | 1.11 | 2.37 | 2.44 | 2.11 | Upgrade
|
| Dividend Per Share | - | - | 0.880 | 1.780 | 1.280 | 0.329 | Upgrade
|
| Dividend Growth | - | - | -50.56% | 39.06% | 289.06% | 141.91% | Upgrade
|
| Gross Margin | 33.45% | 33.15% | 36.48% | 43.13% | 47.29% | 46.69% | Upgrade
|
| Operating Margin | 6.30% | 6.64% | 4.86% | 21.10% | 22.81% | 21.65% | Upgrade
|
| Profit Margin | -5.73% | -5.30% | 7.53% | 17.80% | 18.58% | 18.31% | Upgrade
|
| Free Cash Flow Margin | 9.44% | 6.40% | 6.04% | 7.16% | 9.51% | 11.80% | Upgrade
|
| EBITDA | 874.49 | 922.81 | 859.27 | 3,679 | 3,056 | 2,066 | Upgrade
|
| EBITDA Margin | 12.83% | 12.83% | 10.06% | 23.77% | 25.59% | 25.06% | Upgrade
|
| D&A For EBITDA | 445.43 | 445.21 | 444.34 | 412.85 | 331.56 | 280.85 | Upgrade
|
| EBIT | 429.06 | 477.6 | 414.93 | 3,266 | 2,724 | 1,785 | Upgrade
|
| EBIT Margin | 6.30% | 6.64% | 4.86% | 21.10% | 22.81% | 21.65% | Upgrade
|
| Effective Tax Rate | - | - | 13.96% | 14.33% | 13.98% | 13.09% | Upgrade
|
| Revenue as Reported | - | - | 8,540 | 15,476 | 11,943 | 8,244 | Upgrade
|
| Advertising Expenses | - | - | 2.16 | 3.29 | 3.16 | 2.71 | Upgrade
|
Updated Oct 30, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.